IRD logo

IRD
Opus Genetics Inc.

473
Mkt Cap
$381.36M
Volume
870,023.00
52W High
$5.73
52W Low
$0.7031
PE Ratio
-6.36
IRD Fundamentals
Price
$5.36
Prev Close
$5.50
Open
$5.50
50D MA
$4.10
Beta
1.03
Avg. Volume
979,105.37
EPS (Annual)
-$0.797
P/B
24.41
Rev/Employee
$507,000.00
$81.10
Loading...
Loading...
News
all
press releases
Opus Genetics (NASDAQ:IRD) Now Covered by Analysts at Cantor Fitzgerald
Cantor Fitzgerald began coverage on Opus Genetics in a report on Monday. They set an "overweight" rating and a $15.00 price target on the stock...
MarketBeat·13d ago
News Placeholder
More News
News Placeholder
Short Interest in Opus Genetics, Inc. (NASDAQ:IRD) Grows By 81.3%
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) was the target of a significant increase in short interest in March. As of March 13th, there was short interest totaling 2,014,121 shares, an increase of 81.3% from the February 26th total of 1,110,696 shares. Based on an average daily trading...
MarketBeat·16d ago
News Placeholder
Opus Genetics (IRD) to Release Earnings on Monday
Opus Genetics (NASDAQ:IRD) will be releasing earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-opus-genetics-inc-stock...
MarketBeat·20d ago
News Placeholder
Opus Genetics (NASDAQ:IRD) Insider Rabourn Amy Zaremba Sells 2,816 Shares
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Rabourn Amy Zaremba sold 2,816 shares of the business's stock in a transaction on Monday, March 16th. The shares were sold at an average...
MarketBeat·24d ago
News Placeholder
Insider Selling: Opus Genetics (NASDAQ:IRD) Insider Sells 2,816 Shares of Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Rabourn Amy Zaremba sold 2,816 shares of the company's stock in a transaction that occurred on Monday, March 16th. The shares were sold at...
MarketBeat·25d ago
News Placeholder
Insider Selling: Opus Genetics (NASDAQ:IRD) Insider Sells $19,041.28 in Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) insider Ashwath Jayagopal sold 3,719 shares of Opus Genetics stock in a transaction on Monday, March 16th. The shares were sold at an average price...
MarketBeat·25d ago
News Placeholder
Joseph Schachle Sells 3,719 Shares of Opus Genetics (NASDAQ:IRD) Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) COO Joseph Schachle sold 3,719 shares of the business's stock in a transaction dated Monday, March 16th. The shares were sold at an average price of...
MarketBeat·25d ago
News Placeholder
Insider Selling: Opus Genetics (NASDAQ:IRD) CEO Sells 24,438 Shares of Stock
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) CEO George Magrath sold 24,438 shares of the stock in a transaction on Monday, March 16th. The stock was sold at an average price of $5.21, for a...
MarketBeat·25d ago
News Placeholder
Opus Genetics, Inc. (NASDAQ:IRD) Short Interest Up 17.9% in February
Opus Genetics, Inc. (NASDAQ:IRD - Get Free Report) was the target of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 1,110,696...
MarketBeat·27d ago
News Placeholder
Oppenheimer Initiates Coverage on Opus Genetics (NASDAQ:IRD)
Oppenheimer began coverage on shares of Opus Genetics in a report on Monday. They set an "outperform" rating and a $10.00 price target for the company...
MarketBeat·27d ago
<
1
2
...
>

Latest IRD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.